ArticleAdvances in therapy2026
Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease.
James Amamoo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.